These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
451 related articles for article (PubMed ID: 25077529)
1. Effect of ranibizumab on high-speed indocyanine green angiography and minimum intensity projection optical coherence tomography findings in neovascular age-related macular degeneration. Nicholson BP; Nigam D; Toy B; Stetson PF; Agrón E; Jacobs-El N; Cunningham D; Cukras C; Wong W; Wiley H; Chew E; Ferris F; Meyerle CB Retina; 2015 Jan; 35(1):58-68. PubMed ID: 25077529 [TBL] [Abstract][Full Text] [Related]
2. Changes of choroidal neovascularization in indocyanine green angiography after intravitreal ranibizumab injection. Lee JE; Kim HW; Lee SJ; Lee JE Retina; 2015 May; 35(5):999-1006. PubMed ID: 25590857 [TBL] [Abstract][Full Text] [Related]
3. Earlier therapeutic effects associated with high dose (2.0 mg) Ranibizumab for treatment of vascularized pigment epithelial detachments in age-related macular degeneration. Chan CK; Abraham P; Sarraf D; Nuthi AS; Lin SG; McCannel CA Eye (Lond); 2015 Jan; 29(1):80-7. PubMed ID: 25277305 [TBL] [Abstract][Full Text] [Related]
4. Predictive value of spectral-domain optical coherence tomography features in assessment of visual prognosis in eyes with neovascular age-related macular degeneration treated with ranibizumab. Mathew R; Richardson M; Sivaprasad S Am J Ophthalmol; 2013 Apr; 155(4):720-6, 726.e1. PubMed ID: 23317653 [TBL] [Abstract][Full Text] [Related]
5. OPTICAL COHERENCE TOMOGRAPHY ANGIOGRAPHY CAN CATEGORIZE DIFFERENT SUBGROUPS OF CHOROIDAL NEOVASCULARIZATION SECONDARY TO AGE-RELATED MACULAR DEGENERATION. Arrigo A; Romano F; Aragona E; Di Nunzio C; Battista M; Bandello F; Battaglia Parodi M Retina; 2020 Dec; 40(12):2263-2269. PubMed ID: 32032255 [TBL] [Abstract][Full Text] [Related]
6. Changes in Fundus Autofluorescence after Anti-vascular Endothelial Growth Factor According to the Type of Choroidal Neovascularization in Age-related Macular Degeneration. Lee JY; Chung H; Kim HC Korean J Ophthalmol; 2016 Feb; 30(1):17-24. PubMed ID: 26865799 [TBL] [Abstract][Full Text] [Related]
7. Results of intravitreal ranibizumab with a prn regimen in the treatment of extrafoveal and juxtafoveal neovascular membranes in age-related macular degeneration. Giacomelli G; Giansanti F; Finocchio L; Biagini I; Bacherini D; Virgili G; Menchini U Retina; 2014 May; 34(5):860-7. PubMed ID: 24756034 [TBL] [Abstract][Full Text] [Related]
8. Baseline predictors for one-year visual outcomes with ranibizumab or bevacizumab for neovascular age-related macular degeneration. Ying GS; Huang J; Maguire MG; Jaffe GJ; Grunwald JE; Toth C; Daniel E; Klein M; Pieramici D; Wells J; Martin DF; Ophthalmology; 2013 Jan; 120(1):122-9. PubMed ID: 23047002 [TBL] [Abstract][Full Text] [Related]
9. Response of vascular pigment epithelium detachment due to age-related macular degeneration to monthly treatment with ranibizumab: the prospective, multicentre RECOVER study. Clemens CR; Wolf A; Alten F; Milojcic C; Heiduschka P; Eter N Acta Ophthalmol; 2017 Nov; 95(7):683-689. PubMed ID: 28084038 [TBL] [Abstract][Full Text] [Related]
10. CORRELATION BETWEEN OPTICAL COHERENCE TOMOGRAPHIC HYPERREFLECTIVE FOCI AND VISUAL OUTCOMES AFTER ANTI-VEGF TREATMENT IN NEOVASCULAR AGE-RELATED MACULAR DEGENERATION AND POLYPOIDAL CHOROIDAL VASCULOPATHY. Lee H; Ji B; Chung H; Kim HC Retina; 2016 Mar; 36(3):465-75. PubMed ID: 26076214 [TBL] [Abstract][Full Text] [Related]
11. OPTICAL COHERENCE TOMOGRAPHY LEAKAGE IN NEOVASCULAR AGE-RELATED MACULAR DEGENERATION: Identification of Choroidal Neovascularization Activity by Location and Quantification of Abnormal Fluid Under Anti-Vascular Endothelial Growth Factor Therapy. Farinha C; Santos T; Santos AR; Lopes M; Alves D; Silva R; Cunha-Vaz J Retina; 2020 May; 40(5):881-890. PubMed ID: 30689620 [TBL] [Abstract][Full Text] [Related]
12. Evaluation of choroidal neovascularization with indocyanine green angiography in neovascular age-related macular degeneration subjects undergoing intravitreal bevacizumab therapy. Rush RB; Rush SW; Aragon AV; Ysasaga JE Am J Ophthalmol; 2014 Aug; 158(2):337-44. PubMed ID: 24844972 [TBL] [Abstract][Full Text] [Related]
13. Macular Morphology and Visual Acuity in the Second Year of the Comparison of Age-Related Macular Degeneration Treatments Trials. Sharma S; Toth CA; Daniel E; Grunwald JE; Maguire MG; Ying GS; Huang J; Martin DF; Jaffe GJ; Ophthalmology; 2016 Apr; 123(4):865-75. PubMed ID: 26783095 [TBL] [Abstract][Full Text] [Related]
14. Intravitreal ranibizumab injection for neovascular age-related macular degeneration in phakic versus pseudophakic eyes. Baek JS; Cho HJ; Cho SW; Kim CG; Kim JW Retina; 2013 Mar; 33(3):467-73. PubMed ID: 23400082 [TBL] [Abstract][Full Text] [Related]
15. Subfoveal choroidal thickness as a potential predictor of visual outcome and treatment response after intravitreal ranibizumab injections for typical exudative age-related macular degeneration. Kang HM; Kwon HJ; Yi JH; Lee CS; Lee SC Am J Ophthalmol; 2014 May; 157(5):1013-21. PubMed ID: 24487050 [TBL] [Abstract][Full Text] [Related]
16. Predictability of Recalcitrance in Neovascular Age-Related Macular Degeneration With Indocyanine Green Angiography. Rush RB; Rush SW Asia Pac J Ophthalmol (Phila); 2015; 4(4):187-90. PubMed ID: 26147016 [TBL] [Abstract][Full Text] [Related]
17. [Optical Coherence Tomography Angiography-based Follow-up Observation of Wet Age-related Macular Degeneration after Intravitreal Anti-Ranibizumab Therapy]. Yuan MZ; Zhou HY; Chen YX Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2019 Jun; 41(3):359-366. PubMed ID: 31282330 [TBL] [Abstract][Full Text] [Related]
18. INCIDENCE AND LONG-TERM VISUAL ACUITY OUTCOMES OF RETINAL PIGMENT EPITHELIUM TEARS AFTER INTRAVITREAL ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR TREATMENT OF NEOVASCULAR AGE-RELATED MACULAR DEGENERATION. Vazquez-Alfageme C; Nicholson L; Hamilton RD; Patel PJ Retina; 2019 Apr; 39(4):664-669. PubMed ID: 29324593 [TBL] [Abstract][Full Text] [Related]
19. [Wet form age-related macular degeneration two years treatment results using anti VEGF drugs]. Studnička J; Rencová E; Dusová J; Marák J; Burova M; Rozsíval P; Jarkovský J; Kandrnal V Cesk Slov Oftalmol; 2013 Aug; 69(3):96-101. PubMed ID: 24437955 [TBL] [Abstract][Full Text] [Related]
20. Correlation of indocyanine green angiography and optical coherence tomography findings after intravitreal ranibizumab for polypoidal choroidal vasculopathy. Ueno C; Gomi F; Sawa M; Nishida K Retina; 2012; 32(10):2006-13. PubMed ID: 22772392 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]